Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-08-11

Clinical Trial Update: Clot Dissolving Treatment for Blood Clots in the Lungs [Phase 3]

View source ↗

Summary

Phase 3 clinical trial for a clot-dissolving treatment in pulmonary embolism was terminated; results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: Pulmonary Embolism | Phase 3 | Status: TERMINATED | Results posted: 2014-08-11